In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders". D05A Antipsoriatics for topical use In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use". D05AA Tars D05AC Antracen derivatives D05AC01 Dithranol D05AC51 Dithranol, combinations D05AD Psoralens for topical use D05AD01 Trioxysalen D05AD02 Methoxsalen D05AX Other antipsoriatics for topical use In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use". D05AX01 Fumaric acid D05AX02 Calcipotriol D05AX03 Calcitriol D05AX04 Tacalcitol D05AX05 Tazarotene D05AX52 Calcipotriol, combinations D05AX55 Tazarotene and ulobetasol D05B Antipsoriatics for systemic use In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use". D05BA Psoralens for systemic use D05BA01 Trioxysalen D05BA02 Methoxsalen D05BA03 Bergapten D05BB Retinoids for treatment of psoriasis D05BB01 Etretinate D05BB02 Acitretin D05BX Other antipsoriatics for systemic use In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use". D05BX51 Fumaric acid derivatives, combinations References D05